(MIR) Mirion Technologies - Ratings and Ratios
Radiation Detectors,Dosimetry Tools,Cameras,Gamma Spectrometers,Reactor Sensors
Description: MIR Mirion Technologies
Mirion Technologies Inc (NYSE:MIR) is a leading provider of radiation detection, measurement, analysis, and monitoring products and services across North America, Europe, and the Asia Pacific. The company operates through two primary segments: Medical and Nuclear & Safety.
The Medical segment offers a range of solutions aimed at improving the quality and safety of cancer care delivery, including radiation oncology quality assurance and dosimetry solutions, patient safety solutions, and radionuclide therapy products. This segment supports applications across medical diagnostics and practitioner safety, serving hospitals, clinics, and radiation treatment facilities.
The Nuclear & Safety segment focuses on critical radiation safety, measurement, and analysis applications, providing personal radiation detection, identification equipment, and analysis tools. The companys products and solutions also cater to various industries, including power and utility companies, reactor design firms, and nuclear power plants (NPPs).
From a financial perspective, Mirion Technologies has a market capitalization of approximately $5 billion USD. The companys return on equity (ROE) is currently negative, indicating a need for improvement in profitability. To evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow can be analyzed. Additionally, metrics like debt-to-equity ratio and interest coverage ratio can provide insights into the companys financial health and leverage.
Some key KPIs to monitor for Mirion Technologies include: - Revenue growth rate to assess the companys ability to expand its customer base and increase sales. - Gross margin to evaluate the companys pricing power and cost management. - Operating cash flow to determine the companys ability to generate cash from its core operations. - Debt-to-equity ratio to assess the companys leverage and financial flexibility.
To further analyze Mirion Technologies stock, technical indicators such as relative strength index (RSI), Bollinger Bands, and moving average convergence divergence (MACD) can be used to identify trends and potential trading opportunities.
MIR Stock Overview
| Market Cap in USD | 4,827m |
| Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception | 2020-08-20 |
MIR Stock Ratings
| Growth Rating | 61.9% |
| Fundamental | 68.1% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 94.8% |
| Analyst Rating | 4.60 of 5 |
MIR Dividends
Currently no dividends paidMIR Growth Ratios
| Growth Correlation 3m | 32.3% |
| Growth Correlation 12m | 75.3% |
| Growth Correlation 5y | 34.1% |
| CAGR 5y | 17.08% |
| CAGR/Max DD 5y | 0.27 |
| CAGR/Mean DD 5y | 0.52 |
| Sharpe Ratio 12m | 2.18 |
| Alpha | 111.97 |
| Beta | 0.539 |
| Volatility | 37.51% |
| Current Volume | 36365.3k |
| Average Volume 20d | 1982k |
| Stop Loss | 21.8 (-3.5%) |
| Signal | -0.83 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (10.0m TTM) > 0 and > 6% of Revenue (6% = 65.3m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 1.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 38.68% (prev 33.99%; Δ 4.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 127.2m > Net Income 10.0m (YES >=105%, WARN >=100%) |
| Net Debt (158.0m) to EBITDA (203.3m) ratio: 0.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.54 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (243.6m) change vs 12m ago 20.47% (target <= -2.0% for YES) |
| Gross Margin 51.68% (prev 35.70%; Δ 15.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.56% (prev 31.26%; Δ 9.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.22 (EBITDA TTM 203.3m / Interest Expense TTM 51.6m) >= 6 (WARN >= 3) |
Altman Z'' 0.03
| (A) 0.15 = (Total Current Assets 693.2m - Total Current Liabilities 272.4m) / Total Assets 2.74b |
| (B) -0.19 = Retained Earnings (Balance) -532.9m / Total Assets 2.74b |
| (C) 0.02 = EBIT TTM 62.7m / Avg Total Assets 2.68b |
| (D) -0.48 = Book Value of Equity -589.2m / Total Liabilities 1.22b |
| Total Rating: 0.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 68.05
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 2.09% = 1.05 |
| 3. FCF Margin 10.40% = 2.60 |
| 4. Debt/Equity 0.56 = 2.35 |
| 5. Debt/Ebitda 4.16 = -2.50 |
| 6. ROIC - WACC 3.07% = 3.83 |
| 7. RoE 0.66% = 0.06 |
| 8. Rev. Trend 65.59% = 3.28 |
| 9. Rev. CAGR 42.35% = 2.50 |
| 10. EPS Trend 75.39% = 1.88 |
| 11. EPS CAGR 31.02% = 2.50 |
What is the price of MIR shares?
Over the past week, the price has changed by +9.66%, over one month by +7.52%, over three months by +10.35% and over the past year by +134.20%.
Is Mirion Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MIR is around 22.84 USD . This means that MIR is currently overvalued and has a potential downside of 1.06%.
Is MIR a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MIR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 22.8 | 1% |
| Analysts Target Price | 22.8 | 1% |
| ValueRay Target Price | 25.4 | 12.2% |
Last update: 2025-08-28 04:45
MIR Fundamental Data Overview
CCE Cash And Equivalents = 262.6m USD (last quarter)
P/E Trailing = 418.8
P/S = 5.448
P/B = 3.3009
Beta = 0.831
Revenue TTM = 1.09b USD
EBIT TTM = 62.7m USD
EBITDA TTM = 203.3m USD
Long Term Debt = 832.4m USD (from longTermDebt, last quarter)
Short Term Debt = 13.8m USD (from shortTermDebt, last quarter)
Debt = 846.2m USD (Calculated: Short Term 13.8m + Long Term 832.4m)
Net Debt = 158.0m USD (from netDebt column, last quarter)
Enterprise Value = 5.41b USD (4.83b + Debt 846.2m - CCE 262.6m)
Interest Coverage Ratio = 1.22 (Ebit TTM 62.7m / Interest Expense TTM 51.6m)
FCF Yield = 2.09% (FCF TTM 113.2m / Enterprise Value 5.41b)
FCF Margin = 10.40% (FCF TTM 113.2m / Revenue TTM 1.09b)
Net Margin = 0.92% (Net Income TTM 10.0m / Revenue TTM 1.09b)
Gross Margin = 51.68% ((Revenue TTM 1.09b - Cost of Revenue TTM 525.7m) / Revenue TTM)
Tobins Q-Ratio = -9.18 (set to none) (Enterprise Value 5.41b / Book Value Of Equity -589.2m)
Interest Expense / Debt = 1.39% (Interest Expense 11.8m / Debt 846.2m)
Taxrate = -8.97% (set to none) (-700.0k / 7.80m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.54 (Total Current Assets 693.2m / Total Current Liabilities 272.4m)
Debt / Equity = 0.56 (Debt 846.2m / last Quarter total Stockholder Equity 1.51b)
Debt / EBITDA = 4.16 (Net Debt 158.0m / EBITDA 203.3m)
Debt / FCF = 7.48 (Debt 846.2m / FCF TTM 113.2m)
Total Stockholder Equity = 1.51b (last 4 quarters mean)
RoA = 0.37% (Net Income 10.0m, Total Assets 2.74b )
RoE = 0.66% (Net Income TTM 10.0m / Total Stockholder Equity 1.51b)
RoCE = 2.68% (Ebit 62.7m / (Equity 1.51b + L.T.Debt 832.4m))
RoIC = 3.07% (Ebit 62.7m / (Assets 2.74b - Current Assets 693.2m))
WACC = unknown (E(4.83b)/V(5.67b) * Re(8.0%)) + (D(846.2m)/V(5.67b) * Rd(1.39%) * (1-Tc(none)))
Shares Correlation 5-Years: 100.0 | Cagr: 13.88%
Discount Rate = 8.0% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 79.64% ; FCFE base≈94.1m ; Y1≈103.7m ; Y5≈133.7m
Fair Price DCF = 10.36 (DCF Value 2.33b / Shares Outstanding 224.4m; 5y FCF grow 11.74% → 3.0% )
Revenue Correlation: 65.59 | Revenue CAGR: 42.35%
Rev Growth-of-Growth: 17.79
EPS Correlation: 75.39 | EPS CAGR: 31.02%
EPS Growth-of-Growth: 44.23
Additional Sources for MIR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle